Fresenius Medical Care AG (FMS)
19.96
-0.25
(-1.24%)
USD |
NYSE |
Apr 26, 10:45
Fresenius Medical Care Net Income (TTM): 540.03M for Dec. 31, 2023
Net Income (TTM) Chart
Historical Net Income (TTM) Data
Date | Value |
---|---|
December 31, 2023 | 540.03M |
September 30, 2023 | 479.58M |
June 30, 2023 | 619.54M |
March 31, 2023 | 623.21M |
December 31, 2022 | 707.03M |
September 30, 2022 | 826.72M |
June 30, 2022 | 916.85M |
March 31, 2022 | 1.024B |
December 31, 2021 | 1.147B |
September 30, 2021 | 1.097B |
June 30, 2021 | 1.188B |
March 31, 2021 | 1.311B |
December 31, 2020 | 1.323B |
September 30, 2020 | 1.491B |
June 30, 2020 | 1.448B |
March 31, 2020 | 1.346B |
December 31, 2019 | 1.342B |
September 30, 2019 | 1.447B |
June 30, 2019 | 1.408B |
March 31, 2019 | 2.310B |
December 31, 2018 | 2.345B |
September 30, 2018 | 2.324B |
June 30, 2018 | 2.356B |
March 31, 2018 | 1.465B |
December 31, 2017 | 1.451B |
Date | Value |
---|---|
September 30, 2017 | 1.379B |
June 30, 2017 | 1.355B |
March 31, 2017 | 1.357B |
December 31, 2016 | 1.264B |
September 30, 2016 | 1.225B |
June 30, 2016 | 1.144B |
March 31, 2016 | 1.083B |
December 31, 2015 | 1.067B |
September 30, 2015 | 1.089B |
June 30, 2015 | 1.113B |
March 31, 2015 | 1.111B |
December 31, 2014 | 1.097B |
September 30, 2014 | 1.049B |
June 30, 2014 | 1.034B |
March 31, 2014 | 1.063B |
December 31, 2013 | 1.091B |
September 30, 2013 | 989.01M |
June 30, 2013 | 983.62M |
March 31, 2013 | 1.014B |
December 31, 2012 | 1.145B |
September 30, 2012 | 1.279B |
June 30, 2012 | 1.307B |
March 31, 2012 | 1.273B |
December 31, 2011 | 1.123B |
September 30, 2011 | 1.058B |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (TTM) Range, Past 5 Years
479.58M
Minimum
Sep 2023
1.491B
Maximum
Sep 2020
1.068B
Average
1.147B
Median
Dec 2021
Net Income (TTM) Benchmarks
Biodexa Pharmaceuticals Plc | -8.826M |
NuCana PLC | -34.32M |
Biophytis SA | -18.44M |
TC BioPharm (Holdings) PLC | -7.333M |
DaVita Inc | 691.54M |